Holen Sie sich die Stockscreener-App
3.23
1.36%
-0.07
Handel nachbörslich:
3.22
-0.010
-0.31%
Schlusskurs vom Vortag:
$3.30
Offen:
$3.21
24-Stunden-Volumen:
1.29M
Relative Volume:
0.89
Marktkapitalisierung:
$467.31M
Einnahmen:
$288.95M
Nettoeinkommen (Verlust:
$-119.03M
KGV:
-3.5869
EPS:
-0.9005
Netto-Cashflow:
$60.67M
1W Leistung:
-1.66%
1M Leistung:
+21.91%
6M Leistung:
+83.90%
1J Leistung:
-60.59%
1-Tages-Spanne:
$3.195
$3.325
1-Wochen-Bereich:
$3.14
$3.46
52-Wochen-Spanne:
$1.665
$8.535
Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile
Firmenname
Maravai Lifesciences Holdings Inc
Sektor
Branche
Telefon
(858) 546-0004
Adresse
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Vergleichen Sie MRVI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRVI
Maravai Lifesciences Holdings Inc
|
3.23 | 461.52M | 288.95M | -119.03M | 60.67M | -0.9005 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-12-19 | Eingeleitet | Guggenheim | Neutral |
| 2024-12-05 | Herabstufung | Goldman | Neutral → Sell |
| 2024-11-14 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-08 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-08-13 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-04-10 | Eingeleitet | Craig Hallum | Buy |
| 2023-12-12 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-08-08 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-23 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2023-05-09 | Herabstufung | Goldman | Buy → Neutral |
| 2023-01-05 | Herabstufung | UBS | Buy → Neutral |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-11-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-12-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | Eingeleitet | BofA Securities | Buy |
| 2020-12-15 | Eingeleitet | Credit Suisse | Outperform |
| 2020-12-15 | Eingeleitet | Goldman | Buy |
| 2020-12-15 | Eingeleitet | Jefferies | Buy |
| 2020-12-15 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-12-15 | Eingeleitet | Stifel | Buy |
| 2020-12-15 | Eingeleitet | William Blair | Outperform |
| 2020-12-14 | Eingeleitet | UBS | Buy |
Alle ansehen
Maravai Lifesciences Holdings Inc Aktie (MRVI) Neueste Nachrichten
Applying Wyckoff theory to Maravai LifeSciences Holdings Inc. stockQuarterly Profit Report & Long-Term Investment Growth Plans - newser.com
Will Maravai LifeSciences Holdings Inc. stock outperform tech sector in 2025Weekly Profit Analysis & AI Optimized Trading Strategy Guides - newser.com
Tools to assess Maravai LifeSciences Holdings Inc.’s risk profileJuly 2025 EndofMonth & Low Risk Entry Point Tips - newser.com
Is Maravai LifeSciences Holdings Inc. stock ready for a breakoutInsider Selling & Smart Allocation Stock Tips - newser.com
Chart overlay techniques for tracking Maravai LifeSciences Holdings Inc.Bond Market & Safe Capital Investment Plans - newser.com
Has Maravai LifeSciences Holdings Inc. formed a bullish divergenceSell Signal & Daily Volume Surge Trade Alerts - newser.com
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives Consensus Rating of “Hold” from Analysts - Defense World
Will Maravai LifeSciences Holdings Inc. (MAR) stock beat growth indexesPortfolio Return Report & Free Accurate Trade Setup Notifications - newser.com
Why Maravai LifeSciences Holdings Inc. (MAR) stock appeals to dividend investorsBull Run & Safe Capital Growth Stock Tips - newser.com
Research Frontiers And 2 Other Promising Penny Stocks To Watch - simplywall.st
Custom watchlist performance reports with Maravai LifeSciences Holdings Inc.Trend Reversal & Weekly High Conviction Ideas - newser.com
Detecting support and resistance levels for Maravai LifeSciences Holdings Inc.Portfolio Risk Report & Fast Exit and Entry Trade Guides - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Reach Out - ACCESS Newswire
What data driven models say about Maravai LifeSciences Holdings Inc.’s futureWeekly Investment Report & Technical Confirmation Alerts - newser.com
How high can Maravai LifeSciences Holdings Inc. stock goJuly 2025 Opening Moves & Safe Entry Zone Tips - newser.com
Multi asset correlation models including Maravai LifeSciences Holdings Inc. - newser.com
How to interpret RSI for Maravai LifeSciences Holdings Inc. stockGap Down & Weekly Setup with High ROI Potential - newser.com
How hedge fund analytics apply to Maravai LifeSciences Holdings Inc. stockTrend Reversal & Safe Investment Capital Preservation Plans - newser.com
Maravai LifeSciences stock plunges 39% amid lowered revenue forecast - MSN
Maravai LifeSciences (NASDAQ:MRVI) Trading 5.9% HigherShould You Buy? - MarketBeat
What’s next for Maravai LifeSciences Holdings Inc. stock priceGap Down & Low Drawdown Momentum Ideas - newser.com
Maravai LifeSciences Holdings Inc.’s volatility index tracking explainedJuly 2025 Final Week & Expert Approved Trade Ideas - newser.com
Tools to monitor Maravai LifeSciences Holdings Inc. recovery probabilityQuarterly Market Summary & AI Powered Market Entry Strategies - newser.com
Is Maravai LifeSciences Holdings Inc. stock entering bullish territory2025 Trading Recap & Risk Controlled Stock Alerts - newser.com
How supply shortages influence Maravai LifeSciences Holdings Inc. (MAR) stockWeekly Stock Analysis & Daily Entry Point Trade Alerts - newser.com
Using Python tools to backtest Maravai LifeSciences Holdings Inc. strategiesStock Surge & Verified Short-Term Plans - newser.com
Maravai postpones earnings release, delays annual report - MSN
Avantor, Inc. Appoints Gregory T. Lucier to Its Board of Directors - MarketScreener
Key resistance and support levels for Maravai LifeSciences Holdings Inc.2025 Risk Factors & Safe Capital Allocation Plans - newser.com
MARAVAI (MRVI) INVESTIGATION ALERT: Bragar Eagel & Squire, - GlobeNewswire
Voya Investment Management LLC Reduces Holdings in Maravai LifeSciences Holdings, Inc. $MRVI - Defense World
Finanzdaten der Maravai Lifesciences Holdings Inc-Aktie (MRVI)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):